Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 194 of 1,261
  1. US 11654293

    Laser assisted wound healing protocol and system

    THE BIOREGENTECH INSTITUTE, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  2. US 11655291

    Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  3. US 11654166

    Therapeutic bacteriophage compositions for treating Staphylococcus infection

    Armata Pharmaceuticals, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  4. US 11654124

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    AMNEAL PHARMACEUTICALS LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  5. US 11655454

    Method and apparatus for improved mesenchymal stem cell harvesting

    Elite IP, LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  6. US 11655248

    Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

    Medshine Discovery Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  7. US 11655469

    MicroRNAs and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  8. US 11654097

    Peptide having activities of skin whitening and uses thereof

    CAREGEN CO., LTD. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  9. US 11654147

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  10. US 11654182

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  11. CA 3240096

    POLYTHERAPIE POUR LE TRAITEMENT DU CANCER DU POUMON

    NOVARTIS AG [CH] · Granted May 19, 2023 · Expires May 14, 2043

    granted
  12. US 11648318

    Anti-transferrin receptor (TFR) antibody and uses thereof

    Dyne Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  13. US 11648232

    Methods and compositions for treating excessive sleepiness

    AXSOME MALTA LTD. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  14. US 11649218

    C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2023 · Expires May 11, 2043

    granted
  15. US 11649207

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  16. US 11648297

    Bioresponsive particles

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  17. US 11649468

    Targeted integration into the PPP1R12C locus

    Sangamo Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  18. US 11649459

    Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases

    Alnylam Pharmaceuticals, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  19. US 11649230

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted May 16, 2023 · Expires May 11, 2043

    granted
  20. US 11648267

    Methods and compositions for gene inactivation

    Sangamo Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  21. US 11648274

    Polypeptide

    AUTOLUS LIMITED · Granted May 16, 2023 · Expires May 11, 2043

    granted
  22. US 11648272

    Human kynureninase enzymes and uses thereof

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  23. US 11649206

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted May 16, 2023 · Expires May 11, 2043

    granted
  24. US 11649209

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 16, 2023 · Expires May 11, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.